-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, Johnson & Johnson Vision, a subsidiary of Johnson & Johnson, announced that the US FDA has approved the company’s ACUVUE Abiliti therapeutic contact lens to be marketed.
Myopia is a progressive chronic eye disease.
Myopia does not only affect vision.
Orthokeratology contact lenses are contact lenses that are individually designed for the shape of the patient's cornea.
ACUVUE Abiliti is a orthokeratology contact lens for patients to wear at night, and does not need to be worn during the day.
Note: The original text has been deleted
Reference materials:
[1] Johnson & Johnson Vision Announces FDA Approval ofACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management.
[2] Baird et al.